Abstract No. 39: Transcatheter Arterial Chemoembolization (TACE) Combined Percutaneous Thermal Ablation in Large Hepatocellular Carcinoma: Clinical Observation of the Efficacy and Predictors of Prognostic Factors
J. Li,W. Fan,J. Yang,Y. Wang,W. Chen,X. Xie,M. Lu
DOI: https://doi.org/10.1016/j.jvir.2011.12.074
IF: 3.682
2012-01-01
Journal of Vascular and Interventional Radiology
Abstract:To evaluate safety and efficacy of transcatheter arterial chemoembolazition (TACE) in combination with thermal ablation (radiofrequency ablation, RFA and microwave ablation, MWA) in the treatment of large hepatocellular carcinomas (HCCs). All 66 patients with three or fewer HCCs with a maximum tumor measuring 5.1 cm to 10.0 cm (34 ranging 5.1-7.0 cm, 22 ranging 7.1-9.0 cm and 10 ranging 9.1-10.0 cm) were treated with TACE and thermal ablation. There were 33 patients treated with TACE+RFA and the other were treated with TACE+MWA. Ablations were performed under ultrasound guidance 10-14 days after TACE. Efficacy, long-term survival and prognostic factors were evaluated. There were no treatment related deaths, and the major complication rate was 4.5%. Local recurrence and distant recurrence were 58.1% and 65.2% respectively. The 1-, 2- and 3-year overall survival rate were 80.3%, 33.3%, 13.6% respectively. The Log-rank test showed that tumor size > 9.0 cm, multiple lesions, incomplete necrosis of tumors, pretreatment AFP level > 200 ng/ml and liver cirrhosis were 5 unfavorable prognostic factors for long-term survival (P=.033, .019, .037, .026, .025, respectively). Cox regression analysis confirmed that these five factors were independent unfavorable prognostic factors for patients with large HCCs (Exp(B) =3.962, 1.626, 3.021, 1.235, 2.533, P=.013, .030, .029, .017, 044). TACE combined with percutaneous thermal ablation was a safe and effective treatment for large HCCs. This combination therapy in patients with tumor ranging 7.1 cm to 9.0 cm, as improved efficacy and survival, was recommended. AFP level, tumor number, tumor size, completeness of ablation, cirrhosis were significant prognostic factors.